PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 16, 2026Cureus0 citationsOpen Access

Tjalma Syndrome: A Rare Autoimmune Cause of Multisystem Serositis

AKAaditya KodamanchileSESowmya EkhelikarAAAhmad Kamal Azri AbiMusaAsa'ari

Key Points

  • To report a case of Tjalma syndrome as a rare manifestation of systemic lupus erythematosus (SLE).
  • Case report of a woman with recurrent symptoms and elevated CA-125 levels.
  • Immunological testing confirmed systemic lupus erythematosus after initial evaluations.
  • Treatment included immunosuppressants like corticosteroids and hydroxychloroquine.
  • Patient showed symptomatic improvement following immunosuppressive therapy.
  • Complications included constrictive pericarditis requiring surgery and inflammatory arthritis.
  • Diagnosis of Tjalma syndrome was confirmed due to specific clinical features and elevated tumor marker.

Abstract

Tjalma syndrome is a rare manifestation of systemic lupus erythematosus (SLE) characterized by pleural effusion, ascites, and elevated cancer antigen 125 (CA-125) levels in the absence of ovarian malignancy. We report the case of a woman in her 50s who presented with recurrent pleuritic chest pain, dyspnea, peripheral edema, ascites, and constitutional symptoms. Initial investigations were inconclusive, resulting in repeated admissions and multidisciplinary referrals. Subsequent immunological testing confirmed SLE. Given the constellation of serositis and elevated CA-125, a diagnosis of Tjalma syndrome was established. Treatment with immunosuppressants such as corticosteroids, hydroxychloroquine, and azathioprine resulted in symptomatic improvement. However, the disease course was complicated by constrictive pericarditis requiring pericardiectomy and later inflammatory arthritis requiring escalation of immunosuppression. This case highlights the importance of considering autoimmune etiologies in patients with unexplained multisystem effusions and elevated tumor markers, thereby avoiding misdiagnosis and unnecessary oncological interventions.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kodamanchile et al. (2026) studied this question.

synapsesocial.com/papers/69b79df38166e15b153ab185https://doi.org/10.7759/cureus.105188
Ask AI
Helpful
Bookmark
Share
View Full Paper